Bildkälla: Stockfoto

Active Biotech: Update with Tasquinimod in MM - Redeye

Redeye comments on the latest readout from the trial of tasquinimod in multiple myeloma.

Redeye comments on the latest readout from the trial of tasquinimod in multiple myeloma.
Börsvärldens nyhetsbrev
ANNONSER